Ranolazine
Back to searchMolecule Structure
Scientific Name
Ranolazine
Description of the Drug
Ranolazine is an anti-anginal drug used for the treatment of chronic angina.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00243
http://www.drugbank.ca/drugs/DB00243
Brand Name(s)
Aspruzyo sprinkle, Ranexa, Ranolazine
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Cipla Ltd, Mankind Pharma Ltd, Gilead Sciences Inc, Amneal Pharmaceuticals Llc, Graviti Pharmaceuticals Private Ltd, Micro Labs Ltd, Sun Pharma Industries Ltd, Ajanta Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel protein type V alpha subunit | SINGLE PROTEIN | BLOCKER | CHEMBL1980 |
| Sodium channel protein type IV alpha subunit | SINGLE PROTEIN | BLOCKER | CHEMBL2072 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL124665 | |
| PharmGKB | PA164746007 | |
| Human Metabolome Database | HMDB0014388 | |
| DrugBank | DB00243 | |
| PubChem: Thomson Pharma | 14856376 | |
| PubChem | 56959 | |
| Mcule | MCULE-8182023610 | |
| LINCS | LSM-1952 | |
| Nikkaji | J3.066.456F | |
| BindingDB | 50173335 | |
| EPA CompTox Dashboard | DTXSID3045196 | |
| DrugCentral | 2359 | |
| Brenda | 143790 | |
| ChemicalBook | CB21025015 | CB5195172 |
| Guide to Pharmacology | 7291 | |
| rxnorm | RANOLAZINE | RANEXA |
| PubChem: Drugs of the Future | 12013498 | |
| ChEBI | 87690 |
